<p><strong>Reliance Global Group, Inc.</strong> (NASDAQ:RELI) 的股票在经历了一段动荡期后，最近一个月表现非常出色，涨幅达到 78%。然而，30 天的涨幅并不能改变长期股东在过去 12 个月中因股价下跌 67% 而遭受重创的事实。</p>
<p>尽管价格有了明显反弹，但考虑到美国保险行业约一半的公司市销率（或称 &#34;P/S&#34;）超过 1.1 倍，您仍然可以将 Reliance Global Group 视为一个有吸引力的投资，因其市销率为 0.5 倍。然而，市销率低可能是有原因的，需要进一步调查以确定其合理性。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>查看我们对 Reliance Global Group 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/254784539-ps-multiple-vs-industry-1-dark-2/1750243013784?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/254784539-ps-multiple-vs-industry-1-dark-2/1750243013784"/></p>
<p>NasdaqCM:RELI 市销率与行业比较 2025 年 6 月 18 日</p>
<h3>Reliance Global Group 最近的表现如何？</h3>
<p>我们不得不说，在过去一年中几乎没有实质性增长的情况下，Reliance Global Group 的收入表现并不令人印象深刻。一个可能性是，市销率低是因为投资者认为这种温和的收入增长率在不久的将来可能会落后于更广泛的行业。如果不是这样，那么现有股东可能对股价的未来走势感到乐观。</p>
<p>我们没有分析师的预测，但您可以通过查看我们关于 Reliance Global Group 的 <strong>免费</strong> 报告，了解最近的趋势如何为公司未来铺路，包括其收益、收入和现金流。</p>
<h2>收入增长指标告诉我们关于低市销率的什么？</h2>
<p>您唯一会真正感到舒适的情况是，当公司的增长预计将落后于行业时，市销率低至 Reliance Global Group 的水平。</p>
<p>回顾过去，我们看到公司在过去一年几乎没有可言的收入增长。然而，在此之前的几年强劲表现使得它在过去三年中总收入增长了令人印象深刻的 36%。因此，可以公平地说，最近的收入增长对公司来说是很好的，但投资者会想问为什么增长速度减缓到如此程度。</p>
<p>与行业一年增长预测 5.2% 相比，最近的中期收入轨迹显得更加诱人。</p>
<p>考虑到这一点，我们发现 Reliance Global Group 的市销率与其行业同行相比并不高。显然，一些股东认为最近的表现已经超出了其极限，并接受了显著较低的售价。</p>
<p><img src="https://imageproxy.pbkrs.com/https://media.simplywall.st/news/1748322310639-Valuation_banner.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://media.simplywall.st/news/1748322310639-Valuation_banner.png"/></p>
<h2>关键要点</h2>
<p>尽管 Reliance Global Group 的股价最近上涨，但其市销率仍落后于大多数其他公司。仅仅使用市销率来判断您是否应该卖出股票并不明智，但它可以作为公司未来前景的实用指南。</p>
<p>我们对 Reliance Global Group 的审查显示，其三年收入趋势并没有像我们预期的那样大幅提升其市销率，尽管这些趋势看起来好于当前行业预期。当我们看到强劲的收入和快于行业的增长时，我们假设公司盈利能力存在一些重大潜在风险，这对市销率施加了向下压力。如果最近的中期收入趋势持续，价格风险看起来非常低，但投资者似乎认为未来收入可能会出现较大波动。</p>
<p>此外，您还应该了解我们发现的 <strong>Reliance Global Group 的 5 个警示信号</strong>。</p>
<p>如果您对 Reliance Global Group 的业务实力 <strong>不确定</strong>，为什么不探索我们互动式的股票列表，寻找一些您可能错过的基本面稳健的其他公司呢？</p>

RELI

EZRA

<p>Reliance Global Group, Inc.（纳斯达克代码：RELI）的股价最近飙升了 78%，然而长期投资者在过去一年中面临 67% 的下跌。尽管其市销率（P/S）仅为 0.5 倍，显示出潜在的吸引力，但收入增长却停滞不前。该公司的近期表现引发了人们对其能否与行业增长预期竞争的担忧。分析师指出，低市销率可能反映了投资者对未来收入稳定性的怀疑。尽管近期股价上涨，但仍需谨慎，因为潜在风险可能影响盈利能力</p>

<p><strong>Reliance Global Group, Inc.</strong> (NASDAQ:RELI) shares have had a really impressive month, gaining 78% after a shaky period beforehand. Still, the 30-day jump doesn't change the fact that longer term shareholders have seen their stock decimated by the 67% share price drop in the last twelve months.</p>
<div class="lb-trans"><p><strong>Reliance Global Group, Inc.</strong> (NASDAQ:RELI) 的股票在经历了一段动荡期后，最近一个月表现非常出色，涨幅达到 78%。然而，30 天的涨幅并不能改变长期股东在过去 12 个月中因股价下跌 67% 而遭受重创的事实。</p>
</div><p>In spite of the firm bounce in price, given about half the companies operating in the United States' Insurance industry have price-to-sales ratios (or &#34;P/S&#34;) above 1.1x, you may still consider Reliance Global Group as an attractive investment with its 0.5x P/S ratio. However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.</p>
<div class="lb-trans"><p>尽管价格有了明显反弹，但考虑到美国保险行业约一半的公司市销率（或称 &#34;P/S&#34;）超过 1.1 倍，您仍然可以将 Reliance Global Group 视为一个有吸引力的投资，因其市销率为 0.5 倍。然而，市销率低可能是有原因的，需要进一步调查以确定其合理性。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>See our latest analysis for Reliance Global Group</p>
<div class="lb-trans"><p>查看我们对 Reliance Global Group 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/254784539-ps-multiple-vs-industry-1-dark-2/1750243013784" alt="" original-src="https://images.simplywall.st/asset/chart/254784539-ps-multiple-vs-industry-1-dark-2/1750243013784"/></p>
<p>NasdaqCM:RELI Price to Sales Ratio vs Industry June 18th 2025</p>
<div class="lb-trans"><p>NasdaqCM:RELI 市销率与行业比较 2025 年 6 月 18 日</p>
</div><h3>What Does Reliance Global Group's Recent Performance Look Like?</h3>
<div class="lb-trans"><h3>Reliance Global Group 最近的表现如何？</h3>
</div><p>We'd have to say that with no tangible growth over the last year, Reliance Global Group's revenue has been unimpressive. One possibility is that the P/S is low because investors think this benign revenue growth rate will likely underperform the broader industry in the near future. If not, then existing shareholders may be feeling optimistic about the future direction of the share price.</p>
<div class="lb-trans"><p>我们不得不说，在过去一年中几乎没有实质性增长的情况下，Reliance Global Group 的收入表现并不令人印象深刻。一个可能性是，市销率低是因为投资者认为这种温和的收入增长率在不久的将来可能会落后于更广泛的行业。如果不是这样，那么现有股东可能对股价的未来走势感到乐观。</p>
</div><p>We don't have analyst forecasts, but you can see how recent trends are setting up the company for the future by checking out our <strong>free</strong> report on Reliance Global Group's earnings, revenue and cash flow.</p>
<div class="lb-trans"><p>我们没有分析师的预测，但您可以通过查看我们关于 Reliance Global Group 的 <strong>免费</strong> 报告，了解最近的趋势如何为公司未来铺路，包括其收益、收入和现金流。</p>
</div><h2>What Are Revenue Growth Metrics Telling Us About The Low P/S?</h2>
<div class="lb-trans"><h2>收入增长指标告诉我们关于低市销率的什么？</h2>
</div><p>The only time you'd be truly comfortable seeing a P/S as low as Reliance Global Group's is when the company's growth is on track to lag the industry.</p>
<div class="lb-trans"><p>您唯一会真正感到舒适的情况是，当公司的增长预计将落后于行业时，市销率低至 Reliance Global Group 的水平。</p>
</div><p>Taking a look back first, we see that there was hardly any revenue growth to speak of for the company over the past year. However, a few strong years before that means that it was still able to grow revenue by an impressive 36% in total over the last three years. Therefore, it's fair to say the revenue growth recently has been great for the company, but investors will want to ask why it has slowed to such an extent.</p>
<div class="lb-trans"><p>回顾过去，我们看到公司在过去一年几乎没有可言的收入增长。然而，在此之前的几年强劲表现使得它在过去三年中总收入增长了令人印象深刻的 36%。因此，可以公平地说，最近的收入增长对公司来说是很好的，但投资者会想问为什么增长速度减缓到如此程度。</p>
</div><p>When compared to the industry's one-year growth forecast of 5.2%, the most recent medium-term revenue trajectory is noticeably more alluring</p>
<div class="lb-trans"><p>与行业一年增长预测 5.2% 相比，最近的中期收入轨迹显得更加诱人。</p>
</div><p>With this in mind, we find it intriguing that Reliance Global Group's P/S isn't as high compared to that of its industry peers. Apparently some shareholders believe the recent performance has exceeded its limits and have been accepting significantly lower selling prices.</p>
<div class="lb-trans"><p>考虑到这一点，我们发现 Reliance Global Group 的市销率与其行业同行相比并不高。显然，一些股东认为最近的表现已经超出了其极限，并接受了显著较低的售价。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://media.simplywall.st/news/1748322310639-Valuation_banner.png" alt="" original-src="https://media.simplywall.st/news/1748322310639-Valuation_banner.png"/></p>
<h2>The Key Takeaway</h2>
<div class="lb-trans"><h2>关键要点</h2>
</div><p>Despite Reliance Global Group's share price climbing recently, its P/S still lags most other companies. Using the price-to-sales ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.</p>
<div class="lb-trans"><p>尽管 Reliance Global Group 的股价最近上涨，但其市销率仍落后于大多数其他公司。仅仅使用市销率来判断您是否应该卖出股票并不明智，但它可以作为公司未来前景的实用指南。</p>
</div><p>Our examination of Reliance Global Group revealed its three-year revenue trends aren't boosting its P/S anywhere near as much as we would have predicted, given they look better than current industry expectations. When we see strong revenue with faster-than-industry growth, we assume there are some significant underlying risks to the company's ability to make money which is applying downwards pressure on the P/S ratio. At least price risks look to be very low if recent medium-term revenue trends continue, but investors seem to think future revenue could see a lot of volatility.</p>
<div class="lb-trans"><p>我们对 Reliance Global Group 的审查显示，其三年收入趋势并没有像我们预期的那样大幅提升其市销率，尽管这些趋势看起来好于当前行业预期。当我们看到强劲的收入和快于行业的增长时，我们假设公司盈利能力存在一些重大潜在风险，这对市销率施加了向下压力。如果最近的中期收入趋势持续，价格风险看起来非常低，但投资者似乎认为未来收入可能会出现较大波动。</p>
</div><p>Plus, you should also learn about these <strong>5 warning signs we've spotted with Reliance Global Group</strong>.</p>
<div class="lb-trans"><p>此外，您还应该了解我们发现的 <strong>Reliance Global Group 的 5 个警示信号</strong>。</p>
</div><p>If you're <strong>unsure about the strength of Reliance Global Group's business</strong>, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.</p>
<div class="lb-trans"><p>如果您对 Reliance Global Group 的业务实力 <strong>不确定</strong>，为什么不探索我们互动式的股票列表，寻找一些您可能错过的基本面稳健的其他公司呢？</p>
</div>

尽管 Reliance Global Group, Inc.（纳斯达克代码：RELI）的股价上涨了 78%，投资者仍然对其收入不完全信服